DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,003,615 | +0.5% | 28,229 | -2.8% | 2.79% | +8.3% |
| Q2 2023 | $6,970,080 | -6.5% | 29,042 | -1.8% | 2.58% | -11.6% |
| Q1 2023 | $7,452,571 | -8.6% | 29,569 | -3.8% | 2.92% | -11.2% |
| Q4 2022 | $8,157,950 | -99.9% | 30,736 | +9.8% | 3.28% | -9.9% |
| Q3 2022 | $7,228,504,000 | +0.9% | 27,986 | -1.0% | 3.64% | +8.0% |
| Q2 2022 | $7,164,982,000 | -15.9% | 28,262 | -2.7% | 3.37% | +3.4% |
| Q1 2022 | $8,521,823,000 | -18.5% | 29,052 | -8.6% | 3.26% | -7.6% |
| Q4 2021 | $10,452,319,000 | +5.8% | 31,769 | -2.1% | 3.53% | -0.0% |
| Q3 2021 | $9,878,165,000 | +9.9% | 32,447 | -3.1% | 3.53% | +16.2% |
| Q2 2021 | $8,984,692,000 | +17.2% | 33,480 | -1.7% | 3.04% | +10.4% |
| Q1 2021 | $7,663,074,000 | -2.5% | 34,046 | -3.8% | 2.75% | -3.9% |
| Q4 2020 | $7,862,868,000 | -1.4% | 35,396 | -4.4% | 2.86% | -12.7% |
| Q3 2020 | $7,972,808,000 | +47.1% | 37,026 | -5.4% | 3.28% | +16.4% |
| Q1 2020 | $5,419,443,000 | -9.8% | 39,155 | +0.0% | 2.82% | +18.5% |
| Q4 2019 | $6,009,356,000 | +4.4% | 39,154 | -1.8% | 2.38% | -5.8% |
| Q3 2019 | $5,758,279,000 | +2.6% | 39,869 | +1.5% | 2.52% | +0.5% |
| Q2 2019 | $5,612,325,000 | +8.5% | 39,269 | +0.3% | 2.51% | +6.8% |
| Q1 2019 | $5,170,696,000 | +26.9% | 39,166 | -0.9% | 2.35% | +8.6% |
| Q4 2018 | $4,075,200,000 | -1.0% | 39,519 | +4.3% | 2.16% | +14.3% |
| Q3 2018 | $4,116,475,000 | +8.0% | 37,884 | -2.0% | 1.89% | -0.1% |
| Q2 2018 | $3,812,897,000 | -5.4% | 38,639 | -6.1% | 1.89% | -2.6% |
| Q1 2018 | $4,028,800,000 | +6.6% | 41,148 | +1.1% | 1.94% | +7.3% |
| Q4 2017 | $3,779,537,000 | +3.2% | 40,719 | -4.6% | 1.81% | -0.9% |
| Q3 2017 | $3,662,463,000 | +2.7% | 42,696 | +1.0% | 1.83% | +0.1% |
| Q2 2017 | $3,567,503,000 | -1.5% | 42,274 | -0.2% | 1.83% | -2.6% |
| Q1 2017 | $3,622,623,000 | +9.7% | 42,355 | -0.2% | 1.88% | +6.2% |
| Q4 2016 | $3,303,063,000 | -5.1% | 42,434 | -4.4% | 1.77% | -7.7% |
| Q3 2016 | $3,481,065,000 | -21.5% | 44,407 | +1.2% | 1.91% | -22.3% |
| Q2 2016 | $4,432,587,000 | +2.1% | 43,887 | -4.1% | 2.46% | +2.0% |
| Q1 2016 | $4,339,466,000 | +1.8% | 45,746 | -0.3% | 2.41% | +1.9% |
| Q4 2015 | $4,261,520,000 | +6.6% | 45,882 | -2.2% | 2.37% | +2.5% |
| Q3 2015 | $3,999,331,000 | -2.1% | 46,935 | -1.6% | 2.31% | +7.4% |
| Q2 2015 | $4,083,071,000 | -8.5% | 47,705 | -9.3% | 2.15% | -2.1% |
| Q1 2015 | $4,463,787,000 | +1.4% | 52,577 | +2.4% | 2.20% | +1.2% |
| Q4 2014 | $4,402,751,000 | +11.0% | 51,368 | -1.6% | 2.17% | +9.1% |
| Q3 2014 | $3,967,676,000 | -10.2% | 52,220 | -6.9% | 1.99% | -6.4% |
| Q2 2014 | $4,416,202,000 | +26.6% | 56,093 | +20.6% | 2.13% | -6.0% |
| Q1 2014 | $3,487,650,000 | -3.2% | 46,502 | -0.4% | 2.26% | -6.3% |
| Q4 2013 | $3,603,310,000 | +11.6% | 46,675 | +0.2% | 2.41% | +0.7% |
| Q3 2013 | $3,229,342,000 | +9.3% | 46,586 | -0.2% | 2.40% | +4.7% |
| Q2 2013 | $2,953,515,000 | – | 46,659 | – | 2.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |